Tag: Darzalex

Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis

pharmanewsdaily- January 16, 2021 0

DARZALEX FASPRO FDA approval for AL amyloidosis : Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured approval from the US Food and Drug ... Read More

Janssen seeks EMA’s expanded approval for DARZALEX in AL amyloidosis

pharmanewsdaily- November 8, 2020 0

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a Type II variation application to the European Medicines Agency (EMA) seeking the expanded approval ... Read More

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

pharmanewsdaily- August 23, 2020 0

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the ... Read More

CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients

pharmanewsdaily- September 13, 2019 0

CANDOR clinical trial results : Amgen said that a phase 3 study assessing Kyprolis (carfilzomib) in combination with dexamethasone and Johnson & Johnson's Darzalex (daratumumab) ... Read More

Janssen bags EC approval for daratumumab for multiple myeloma

pharmanewsdaily- September 1, 2018 0

Janssen Pharmaceutical Companies of Johnson & Johnson has secured marketing authorization for its monoclonal antibody Darzalex (daratumumab) from the European Commission (EC) as initial therapy ... Read More